CO6540004A2 - Métodos y composiciones para el tratamiento rápido de otitis externa - Google Patents

Métodos y composiciones para el tratamiento rápido de otitis externa

Info

Publication number
CO6540004A2
CO6540004A2 CO12092192A CO12092192A CO6540004A2 CO 6540004 A2 CO6540004 A2 CO 6540004A2 CO 12092192 A CO12092192 A CO 12092192A CO 12092192 A CO12092192 A CO 12092192A CO 6540004 A2 CO6540004 A2 CO 6540004A2
Authority
CO
Colombia
Prior art keywords
methods
compositions
treatment
quick treatment
external otitis
Prior art date
Application number
CO12092192A
Other languages
English (en)
Inventor
William R Campbell
Neil E Paulsen
Roland H Johnson
Douglas I Hepler
Original Assignee
Bayer Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43992011&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6540004(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Bv filed Critical Bayer Bv
Publication of CO6540004A2 publication Critical patent/CO6540004A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se proporcionan métodos para el tratamiento y prevención de la otitis externa con un curso de tratamiento que consiste de tan poco como una sola dosis. Los métodos se practican mediante la administración tópica de las composiciones que tienen un portador de lípidos, tal como liposomas y lípidos no vesiculares, al canal auditivo externo. Estas composiciones carecen de celulosas o adhesivos que intensifican la viscosidad, y de preferencia no están en forma de gel. Los agentes activos útiles para el tratamiento de dolor, inflamación, infestación fungal o parasitaria y/o en el oído externo se co-administran en la composición o con la misma.
CO12092192A 2009-11-11 2012-06-01 Métodos y composiciones para el tratamiento rápido de otitis externa CO6540004A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26030909P 2009-11-11 2009-11-11

Publications (1)

Publication Number Publication Date
CO6540004A2 true CO6540004A2 (es) 2012-10-16

Family

ID=43992011

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12092192A CO6540004A2 (es) 2009-11-11 2012-06-01 Métodos y composiciones para el tratamiento rápido de otitis externa

Country Status (28)

Country Link
US (1) US8927006B2 (es)
EP (1) EP2498792B1 (es)
JP (2) JP2013510861A (es)
KR (2) KR20120116398A (es)
CN (1) CN102612372B (es)
AU (1) AU2010319538B2 (es)
BR (1) BR112012011017A2 (es)
CA (1) CA2780160C (es)
CL (1) CL2012001227A1 (es)
CO (1) CO6540004A2 (es)
DK (1) DK2498792T3 (es)
EC (1) ECSP12011967A (es)
ES (1) ES2645200T3 (es)
HR (1) HRP20171520T1 (es)
HU (1) HUE034617T2 (es)
IL (1) IL219483A (es)
LT (1) LT2498792T (es)
MX (1) MX2012005521A (es)
MY (1) MY162687A (es)
NO (1) NO2498792T3 (es)
NZ (1) NZ599559A (es)
PL (1) PL2498792T3 (es)
PT (1) PT2498792T (es)
RU (1) RU2680137C2 (es)
SI (1) SI2498792T1 (es)
UA (1) UA111147C2 (es)
WO (1) WO2011060083A1 (es)
ZA (1) ZA201203239B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014036165A1 (en) * 2012-08-29 2014-03-06 Bayer Healthcare, Llc Aqueous based compositions for treating otitis externa
CN104337952A (zh) * 2013-08-10 2015-02-11 李谊 一种中西医结合治疗爆震性耳聋的组合药物
CN104739768A (zh) * 2013-12-27 2015-07-01 河南惠通天下生物工程有限公司 一种甲砜霉素纳米脂质体及其制备方法
EP3482744A1 (de) * 2017-11-14 2019-05-15 ProFem GmbH Emulsionen zur topischen behandlung urogenitaler und dermaler infektionen
BR112020009458A2 (pt) 2017-11-14 2020-10-27 Profem Gmbh emulsões para o tratamento tópico de infecções cutâneas e infecções das mucosas
BR112022005354A2 (pt) * 2019-09-23 2022-08-23 Dds Res Inc Composições de vesícula lipídica com agentes potencializadores de penetração
US20210106597A1 (en) * 2019-10-11 2021-04-15 Piedmont Animal Health Inc. Otic formulations, methods and devices
CN113876658B (zh) * 2021-11-01 2023-10-20 仙乐健康科技股份有限公司 水包油型乳液组合物及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT744939E (pt) 1994-02-04 2003-02-28 Lipocore Holding Ab Preparacoes em bicamada preparadas a partir de digalactosildiacilglicerol contendo galactolipido
EP0785780A1 (en) * 1994-10-10 1997-07-30 Novartis AG Ophthalmic and aural compositions containing diclofenac potassium
AU708540B2 (en) * 1995-06-06 1999-08-05 Bayer Intellectual Property Gmbh Non-irritation, nonsensitizing, non-ototoxic otic anti-bacterial compositions
IT1295369B1 (it) * 1997-10-21 1999-05-12 Fatro Spa Composizione a base di tiamfenicolo e diclofenac
US6433024B1 (en) * 2000-05-08 2002-08-13 Karl F. Popp Topical anti-acne composition
AUPR798901A0 (en) * 2001-09-28 2001-10-25 Medvet Science Pty. Ltd. Spheroidal hdl particles with a defined phospholipid composition
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US20050013854A1 (en) * 2003-04-09 2005-01-20 Mannino Raphael J. Novel encochleation methods, cochleates and methods of use
JP2007500691A (ja) * 2003-07-31 2007-01-18 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗炎症剤の分散性製剤
US20050159369A1 (en) * 2003-08-20 2005-07-21 Qtm Llc Method of treatment of otitis externa
US20070054844A1 (en) * 2003-08-20 2007-03-08 Fairfield Clinical Trials, Llc Method for treating otitis externa
US20070078116A1 (en) * 2003-08-20 2007-04-05 Fairfield Clinical Trials, Llc Method of treatment of otitis externa
BRPI0514898A (pt) 2004-09-03 2008-06-24 Piedmont Pharmaceuticals Llc métodos para tratamento e prevenção transmembrana da otite média
WO2006099325A2 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of treating ear infections
US20090082337A1 (en) * 2007-09-21 2009-03-26 Srini Venkastesh Compositions Comprising Quinolone and Methods for Treating or Controlling Infections
US20090111780A1 (en) * 2007-10-31 2009-04-30 Everett Laboratories, Inc. Compositions and methods for treatment of ear canal infection and inflammation

Also Published As

Publication number Publication date
RU2680137C2 (ru) 2019-02-18
AU2010319538A1 (en) 2012-05-17
IL219483A (en) 2017-12-31
CA2780160A1 (en) 2011-05-19
PT2498792T (pt) 2017-10-18
RU2012124067A (ru) 2013-12-20
LT2498792T (lt) 2017-10-25
NO2498792T3 (es) 2017-12-30
US8927006B2 (en) 2015-01-06
HUE034617T2 (en) 2018-02-28
MY162687A (en) 2017-07-14
NZ599559A (en) 2014-08-29
KR101901083B1 (ko) 2018-09-20
BR112012011017A2 (pt) 2015-09-15
HRP20171520T1 (hr) 2017-11-17
JP6138891B2 (ja) 2017-05-31
AU2010319538B2 (en) 2015-04-09
US20110281809A1 (en) 2011-11-17
ZA201203239B (en) 2013-07-31
WO2011060083A1 (en) 2011-05-19
CA2780160C (en) 2018-03-06
MX2012005521A (es) 2012-06-19
PL2498792T3 (pl) 2018-01-31
ES2645200T3 (es) 2017-12-04
EP2498792A4 (en) 2013-06-12
DK2498792T3 (da) 2017-11-06
CN102612372A (zh) 2012-07-25
CL2012001227A1 (es) 2012-08-24
ECSP12011967A (es) 2012-08-31
EP2498792B1 (en) 2017-08-02
JP2016102112A (ja) 2016-06-02
SI2498792T1 (sl) 2017-11-30
KR20120116398A (ko) 2012-10-22
EP2498792A1 (en) 2012-09-19
KR20170100680A (ko) 2017-09-04
UA111147C2 (uk) 2016-04-11
IL219483A0 (en) 2012-06-28
CN102612372B (zh) 2016-01-20
JP2013510861A (ja) 2013-03-28

Similar Documents

Publication Publication Date Title
ECSP12011967A (es) Métodos y composiciones para el tratamiento rápido de otitis externa
CL2017003445A1 (es) Formas solidas y formulaciones de compuestos de imidazopirazina.
DOP2012000225A (es) Compuestos de pirrolo-pirimidina como inhibidores de cdk4/6
CU20150163A7 (es) DERIVADOS DE 5-HETEROARIL-4-FENIL-4,5-DIHIDROPIRROLO(3,4-c)PIRAZOL-6-ONA ACTIVOS COMO INHIBIDORES DE BET
PH12016500024A1 (en) Bromodomain inhibitor
CZ308507B6 (cs) Parazitické orální veterinární kompozice obsahující systémově působící aktivní činidla, způsoby a jejich použití
EA201591662A1 (ru) Липиды и липидные композиции для доставки активных агентов
NZ732777A (en) Ionizable cationic lipid for rna delivery
NI201300041A (es) Antagonistas de mdm2 de espiro-oxindol
UY28862A1 (es) Nuevas composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii
ECSP11011459A (es) Composiciones sublinguales de dexmedetomidina y métodos de uso de ellas
ECSP12012171A (es) Composiciones farmacéuticas del compuesto espiro-oxindol para administración tópica y sus usos como agentes terapéuticos
AR081681A1 (es) METODOS Y COMPOSICIONES PARA LA ADMINISTRACION INTRATECAL DE b-GALACTOCEREBROSIDASA
CL2020000747A1 (es) Formulaciones de niraparib.
CO6710926A2 (es) Compuestos de n-heteroarilo
DOP2011000382A (es) Sulfonamidas heterociclicas, usos y composiciones farmaceuticas de las mismas
CL2017000845A1 (es) Inhibidores de gingipaina de lisina
MX342859B (es) Polisacarido de las semillas de tamarindo para usarse en el tratamiento de enfermedades inflamatorias.
CR11823A (es) Compuestos de pirazina fusionados utiles para el tratamiento de enfermedades degenarativas e inflamatorias
ECSP099596A (es) Composición farmacéutica que contiene una combinación de tramadol y ketoprofeno
AR083095A1 (es) Cocristal de aprepitant l-prolina y composicion farmaceutica
BR112022004777A2 (pt) Composição de micela de estimulação imunológica
ECSP13012988A (es) Derivados de tienopirimidina (2,3-d) y su uso para tratar arritmia
MX2014014579A (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
NI201200196A (es) Agentes terapéuticos 976